110 related articles for article (PubMed ID: 19686089)
1. Serum levels of galectin-3 and its ligand 90k/mac-2bp in colorectal cancer patients.
Iacovazzi PA; Notarnicola M; Caruso MG; Guerra V; Frisullo S; Altomare DF; Correale M
Immunopharmacol Immunotoxicol; 2010 Mar; 32(1):160-4. PubMed ID: 19686089
[TBL] [Abstract][Full Text] [Related]
2. Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer.
Wu KL; Chen HH; Pen CT; Yeh WL; Huang EY; Hsiao CC; Yang KD
Biomed Res Int; 2015; 2015():306964. PubMed ID: 26448934
[TBL] [Abstract][Full Text] [Related]
3. Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection.
Kittl EM; Hofmann J; Hartmann G; Sebesta C; Beer F; Bauer K; Huber KR
Clin Chem Lab Med; 2000 Mar; 38(3):205-8. PubMed ID: 10905755
[TBL] [Abstract][Full Text] [Related]
4. Increased serum 90K and Galectin-3 expression are associated with advanced stage and a worse prognosis in diffuse large B-cell lymphomas.
Kim SJ; Lee SJ; Sung HJ; Choi IK; Choi CW; Kim BS; Kim JS; Yu W; Hwang HS; Kim IS
Acta Haematol; 2008; 120(4):211-6. PubMed ID: 19153476
[TBL] [Abstract][Full Text] [Related]
5. [Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma].
Zhang DS; Jiang WQ; Li S; Zhang XS; Mao H; Chen XQ; Li YH; Zhan J; Wang FH
Ai Zheng; 2003 Aug; 22(8):870-3. PubMed ID: 12917038
[TBL] [Abstract][Full Text] [Related]
6. Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis.
Correale M; Giannuzzi V; Iacovazzi PA; Valenza MA; Lanzillotta S; Abbate I; Quaranta M; Caruso ML; Elba S; Manghisi OG
Anticancer Res; 1999; 19(4C):3469-72. PubMed ID: 10629637
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer.
Ulmer TA; Keeler V; Loh L; Chibbar R; Torlakovic E; André S; Gabius HJ; Laferté S
J Cell Biochem; 2006 Aug; 98(5):1351-66. PubMed ID: 16518858
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein 90K/MAC-2BP interacts with galectin-1 and mediates galectin-1-induced cell aggregation.
Tinari N; Kuwabara I; Huflejt ME; Shen PF; Iacobelli S; Liu FT
Int J Cancer; 2001 Jan; 91(2):167-72. PubMed ID: 11146440
[TBL] [Abstract][Full Text] [Related]
9. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients.
Marchetti A; Tinari N; Buttitta F; Chella A; Angeletti CA; Sacco R; Mucilli F; Ullrich A; Iacobelli S
Cancer Res; 2002 May; 62(9):2535-9. PubMed ID: 11980646
[TBL] [Abstract][Full Text] [Related]
10. Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.
Koopmann J; Thuluvath PJ; Zahurak ML; Kristiansen TZ; Pandey A; Schulick R; Argani P; Hidalgo M; Iacobelli S; Goggins M; Maitra A
Cancer; 2004 Oct; 101(7):1609-15. PubMed ID: 15378479
[TBL] [Abstract][Full Text] [Related]
11. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K.
Becker R; Lenter MC; Vollkommer T; Boos AM; Pfaff D; Augustin HG; Christian S
FASEB J; 2008 Aug; 22(8):3059-67. PubMed ID: 18490383
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients.
Artini M; Natoli C; Tinari N; Costanzo A; Marinelli R; Balsano C; Porcari P; Angelucci D; D'Egidio M; Levrero M; Iacobelli S
J Hepatol; 1996 Aug; 25(2):212-7. PubMed ID: 8878784
[TBL] [Abstract][Full Text] [Related]
13. 90K (Mac-2 BP) and galectins in tumor progression and metastasis.
Grassadonia A; Tinari N; Iurisci I; Piccolo E; Cumashi A; Innominato P; D'Egidio M; Natoli C; Piantelli M; Iacobelli S
Glycoconj J; 2002; 19(7-9):551-6. PubMed ID: 14758079
[TBL] [Abstract][Full Text] [Related]
14. Adhesion to 90K (Mac-2 BP) as a mechanism for lymphoma drug resistance in vivo.
Fornarini B; D'Ambrosio C; Natoli C; Tinari N; Silingardi V; Iacobelli S
Blood; 2000 Nov; 96(9):3282-5. PubMed ID: 11050016
[TBL] [Abstract][Full Text] [Related]
15. 90K (Mac-2 BP) in human milk.
D'Ostilio N; Sabatino G; Natoli C; Ullrich A; Iacobelli S
Clin Exp Immunol; 1996 Jun; 104(3):543-6. PubMed ID: 9099942
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3 expression is a potent prognostic marker in colorectal cancer.
Endo K; Kohnoe S; Tsujita E; Watanabe A; Nakashima H; Baba H; Maehara Y
Anticancer Res; 2005; 25(4):3117-21. PubMed ID: 16080575
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of circulating immunostimulatory 90K in Henoch-Schoenlein purpura.
Pelliccia P; Natoli C; Petitti MT; Verrotti A; Chiarelli F; Iacobelli S
J Clin Immunol; 1999 Mar; 19(2):143-7. PubMed ID: 10226889
[TBL] [Abstract][Full Text] [Related]
18. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality.
Betka J; Plzák J; Smetana K; Gabius HJ
Acta Otolaryngol; 2003 Jan; 123(2):261-3. PubMed ID: 12701754
[TBL] [Abstract][Full Text] [Related]
20. Overexpression and elevated plasma level of tumor-associated antigen 90K/Mac-2 binding protein in colorectal carcinoma.
Wu CC; Huang YS; Lee LY; Liang Y; Tang RP; Chang YS; Hsieh LL; Yu JS
Proteomics Clin Appl; 2008 Dec; 2(12):1586-95. PubMed ID: 21136809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
